$12.15
4.56%
Nasdaq, Sep 12, 10:04 pm CET
ISIN
JE00BYSS4X48
Symbol
NVCR

Novocure Ltd. Stock price

$12.15
+0.81 7.14% 1M
-8.47 41.08% 6M
-17.65 59.23% YTD
-5.18 29.89% 1Y
-77.42 86.44% 3Y
-85.55 87.56% 5Y
-6.13 33.53% 10Y
-6.13 33.53% 20Y
Nasdaq, Closing price Fri, Sep 12 2025
-0.58 4.56%

Key metrics

Basic
Market capitalization
$1.4b
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.2 | 2.1
EV/Sales
- | -
EV/FCF
-
P/B
-
Financial Health
Equity Ratio
29.0%
Return on Equity
-46.8%
ROCE
-
ROIC
-
Debt/Equity
-
Financials (TTM | estimate)
Revenue
$630.2m | $645.6m
EBITDA
$-156.9m | $-58.1m
EBIT
$-169.2m | $-176.8m
Net Income
$-171.0m | -
Free Cash Flow
$-80.4m
Growth (TTM | estimate)
Revenue
14.6% | 6.7%
EBITDA
8.7% | 63.1%
EBIT
7.6% | -4.9%
Net Income
-1.3% | -
Free Cash Flow
23.0%
Margin (TTM | estimate)
Gross
76.6%
EBITDA
-24.9% | -9.0%
EBIT
-26.9%
Net
-27.1% | -
Free Cash Flow
-12.8%
More
EPS
$-1.5
FCF per Share
-
Short interest
8.4%
Employees
1k
Rev per Employee
$410.0k
Show more

Is Novocure Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

Novocure Ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Novocure Ltd. forecast:

10x Buy
71%
4x Hold
29%

Analyst Opinions

14 Analysts have issued a Novocure Ltd. forecast:

Buy
71%
Hold
29%

Financial data from Novocure Ltd.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
630 630
15% 15%
100%
- Direct Costs 148 148
11% 11%
23%
483 483
16% 16%
77%
- Selling and Administrative Expenses 439 439
14% 14%
70%
- Research and Development Expense 213 213
1% 1%
34%
-157 -157
9% 9%
-25%
- Depreciation and Amortization 12 12
10% 10%
2%
EBIT (Operating Income) EBIT -169 -169
8% 8%
-27%
Net Profit -171 -171
1% 1%
-27%

In millions USD.

Don't miss a Thing! We will send you all news about Novocure Ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Novocure Ltd. Stock News

Neutral
Seeking Alpha
4 days ago
NovoCure Limited (NASDAQ:NVCR ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 3:20 PM EDT Company Participants Ashley Cordova - CEO & Director Conference Call Participants Kelly McCarthy - Morgan Stanley Presentation Kelly McCarthy Good afternoon, everyone, and we appreciate you joining us for a fireside chat with NovoCure. I'm very happy to be joined by CEO, Ashley...
Positive
The Motley Fool
17 days ago
@coryrenauer Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends NovoCure.
Neutral
Business Wire
18 days ago
BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced today that management will participate in three upcoming investor events. 2025 Wells Fargo Healthcare Conference, September 4, 2025: Ashley Cordova, Chief Executive Officer, will take part in a fireside chat at 9:30 a.m. ET, as well as one-on-one meetings with investors throughout the event. H.C. Wainwright 27th Annual Global...
More Novocure Ltd. News

Company Profile

NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

Head office Jersey
CEO Ms. Cordova
Employees 1,488
Founded 2000
Website www.novocure.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today